European Heart Journal - Cardiovascular Pharmacotherapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 8.2 | Q1 | 94.7% | 2.014 | Q1 | 95.3% |
| 2024 | 6.1 | Q1 | 91.5% | 2.043 | Q1 | 95.5% |
| 2023 | 5.3 | Q1 | 90.9% | 1.507 | Q1 | 92.7% |
| 2022 | 7.1 | Q1 | 92.8% | 1.641 | Q1 | 94.1% |
| 2021 | 11.2 | Q1 | 96.2% | 1.662 | Q1 | 94.2% |
| 2020 | — | — | 1.895 | Q1 | 95.1% | |
| 2019 | — | — | 1.725 | Q1 | 94.2% | |
| 2018 | — | — | 1.779 | Q1 | 93.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2055-6845
ISSN
2055-6837
region
Western Europe
coverage
2015-2026